Physician

Joseph A Stauber, M.D.

According to 2025 Medicare claims, Joseph Stauber, M.D. (NPI: 1548609779) practices rheumatology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is CLAYTON MEDICAL ASSOCIATES, P.C. (NPI: 1891774329; TIN: 43-1907813) and primary practice location at 63119-3845. Stauber is affiliated with the BJC HealthCare ACO, LLC (ACO ID: A1204), Mercy Health ACO, LLC (ACO ID: A2616), IRCCO (ACO ID: A2619), and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Stauber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 207,679 HCPCS/CPT codes, and received $2,864,925 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,402 prescription claims across 423 beneficiaries totaling $831,137 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 254 records totaling $11,951. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $30,239 to $2,864,925. Similarly, Part D prescription costs have risen steadily, from $45,409 to $831,137. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	85	2,386	$30,239
2019	212	17,556	$164,623
2020	197	12,081	$171,314
2021	136	17,475	$698,167
2022	180	26,440	$296,696
2023	256	55,918	$632,729
2024	526	207,679	$2,864,925

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	67	1,080	$45,409
2016	107	1,098	$121,706
2017	97	515	$218,973
2018	121	561	$414,216
2019	219	1,233	$393,285
2020	246	1,264	$335,392
2021	236	636	$342,948
2022	207	552	$196,941
2023	339	932	$287,066
2024	423	1,402	$831,137

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	102	111	$129
96413	Administration of chemotherapy into vein, 1 hour or less	140	927	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	423	1,180	$85
76881	Complete ultrasound scan of joint	106	108	$39
J7050	Infusion, normal saline solution, 250 cc	139	916	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	11	364	$115,949
Pregabalin	Pregabalin	216	6,989	$4,762
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	107	6,270	$3,920
Methotrexate	Methotrexate Sodium	135	6,201	$3,037
Leflunomide	Leflunomide	53	3,500	$2,244

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	241	$4,670	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$7,280	SUN PHARMACEUTICAL INDUSTRIES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph A. Stauber, M.D.?

Tedicare shows public-source Medicare data for Joseph A. Stauber, M.D. (NPI 1548609779), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph A. Stauber, M.D. have ACO affiliation data?

Joseph A. Stauber, M.D. is shown with ACO affiliation data for BJC HealthCare ACO, LLC (MSSP, ACO ID A1204), Mercy Health ACO, LLC (MSSP, ACO ID A2616), IRCCO (MSSP, ACO ID A2619), and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Joseph A. Stauber, M.D.?

Joseph A. Stauber, M.D. is linked to CLAYTON MEDICAL ASSOCIATES, P.C. (billing NPI 1891774329) in the available physician profile data.

Does Joseph A. Stauber, M.D. have Open Payments data?

Joseph A. Stauber, M.D. has 254 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.